Analgesic efficacy of nefopam for cancer pain: a randomized controlled study [version 1; peer review: 2 approved]
Background: Nefopam is a non-opioid, non-steroidal, central acting drug used effectively for postoperative pain. The efficacy of nefopam for cancer pain remains unclear. We aimed to evaluate the analgesic efficacy of nefopam for cancer pain in a randomized controlled trial. Methods: Patients with mo...
Main Authors: | Koravee Pasutharnchat, Wichita Wichachai, Rungrawan Buachai |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2020-05-01
|
Series: | F1000Research |
Online Access: | https://f1000research.com/articles/9-378/v1 |
Similar Items
-
Perioperative Intravenous Patient-Controlled Analgesic Efficacy of Morphine with Combined Nefopam and Parecoxib versus Parecoxib in Gynecologic Surgery: A Randomized, Double-Blind Study
by: Varinee Lekprasert, et al.
Published: (2021-01-01) -
Analgesic efficacy of intravenous nefopam after spine surgery: a randomized, double-blind, placebo-controlled trial [version 2; peer review: 2 approved, 1 approved with reservations]
by: Jatuporn Eiamcharoenwit, et al.
Published: (2020-08-01) -
Factors influencing non-adherence to opioids in cancer patients: a mixed-methods cross-sectional study [version 2; peer review: 2 approved]
by: Rattaphol Seangrung, et al.
Published: (2021-03-01) -
Analgesic Efficacy of Nefopam as an Adjuvant in Patient-Controlled Analgesia for Acute Postoperative Pain After Laparoscopic Colorectal Cancer Surgery
by: Eun Jung Oh, et al.
Published: (2021-01-01) -
The Analgesic Efficacy of Nefopam in Patient-Controlled Analgesia after Laparoscopic Gynecologic Surgery: A Randomized, Double-Blind, Non-Inferiority Study
by: Soomin Lee, et al.
Published: (2021-03-01)